Transmitting Device Identifiers of Implants From the Point of Care to Insurers: A Demonstration Project

For implanted devices, an effective postmarket surveillance system does not exist. For medications, the Food and Drug Administration’s Sentinel Initiative plays that role, relying mainly on drug codes in insurance claims. Unique device identifiers (UDIs) could play an analogous role for implants, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Krupka, Dan C., Graham, Jove, Wilson, Natalia A., Li, Angela, Landman, Adam B., Bhatt, Deepak L., Nguyen, Louis L., Reich, Amanda J., Gupta, Avni, Zerhouni, Yasmin A., Capatch, Kevin J., Concheri, Kevin P., Weissman, Joel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
The Health Care Manager
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984755/
https://www.ncbi.nlm.nih.gov/pubmed/33734207
http://dx.doi.org/10.1097/PTS.0000000000000828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984755/
https://www.ncbi.nlm.nih.gov/pubmed/33734207
http://dx.doi.org/10.1097/PTS.0000000000000828

Ejemplares similares